Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.
Cortés-Bonilla M, Bernardo-Escudero R, Alonso-Campero R, Francisco-Doce MT, Hernández-Valencia M, Celis-González C, Márquez-Oñate R, Chedraui P, Uribe JA. Cortés-Bonilla M, et al. Among authors: alonso campero r. Gynecol Endocrinol. 2015 Jul;31(7):552-9. doi: 10.3109/09513590.2015.1019853. Epub 2015 Jun 10. Gynecol Endocrinol. 2015. PMID: 26062108 Free PMC article. Clinical Trial.
Improvement of quality of life and menopausal symptoms in climacteric women treated with low-dose monthly parenteral formulations of non-polymeric microspheres of 17β-estradiol/progesterone.
Cortés-Bonilla M, Alonso-Campero R, Bernardo-Escudero R, Francisco-Doce MT, Chavarín-González J, Pérez-Cuevas R, Chedraui P. Cortés-Bonilla M, et al. Among authors: alonso campero r. Gynecol Endocrinol. 2016 Oct;32(10):831-834. doi: 10.1080/09513590.2016.1183628. Epub 2016 May 17. Gynecol Endocrinol. 2016. PMID: 27187320 Free article. Clinical Trial.
Observational study of the local tolerability of injectable progesterone microspheres.
Bernardo-Escudero R, Cortés-Bonilla M, Alonso-Campero R, Francisco-Doce MT, Chavarín-González J, Pimentel-Martínez S, Zambrano-Tapia L. Bernardo-Escudero R, et al. Among authors: alonso campero r. Gynecol Obstet Invest. 2012;73(2):124-9. doi: 10.1159/000330711. Epub 2011 Oct 12. Gynecol Obstet Invest. 2012. PMID: 21997608
Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects.
Bernardo-Escudero R, Alonso-Campero R, Francisco-Doce MT, Cortés-Fuentes M, Villa-Vargas M, Angeles-Uribe J. Bernardo-Escudero R, et al. Among authors: alonso campero r. Eur J Drug Metab Pharmacokinet. 2012 Dec;37(4):279-88. doi: 10.1007/s13318-012-0082-0. Epub 2012 Feb 11. Eur J Drug Metab Pharmacokinet. 2012. PMID: 22328192 Clinical Trial.
Comparison of the pharmacokinetics of a new 15-mg modified-release tablet formulation of metoclopramide versus a 10-mg immediate-release tablet: a single- and multiple-dose, randomized, open-label, parallel-group study in healthy Mexican male volunteers.
Bernardo-Escudero R, Alonso-Campero R, de Jesús Francisco-Doce MT, Cortés-Fuentes M, Villa-Vargas M, Angeles-Uribe J. Bernardo-Escudero R, et al. Among authors: alonso campero r. Clin Ther. 2011 May;33(5):630-43. doi: 10.1016/j.clinthera.2011.04.016. Clin Ther. 2011. PMID: 21665047 Clinical Trial.
Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study.
Poo JL, Aguilar JR, Bernal-Reyes R, Alonso-Campero R, Gasca F, Hernández L, Pineyro-Garza E, Gomez-Silva M, Gamino ME, la Parra MG, Peña P, Hernández N, Tapia G, Muñoz-Espinosa LE. Poo JL, et al. Among authors: alonso campero r. Biomed Pharmacother. 2023 Dec;168:115712. doi: 10.1016/j.biopha.2023.115712. Epub 2023 Oct 21. Biomed Pharmacother. 2023. PMID: 37871556 Free article.